CEO Mark J Foley sold $593K of Revance Therapeutics, Inc.

Sold$593,151

$22.57Price

26,279Shares

−3%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Thu, Aug 3. Filed Fri, Aug 4, 1:07 PM ET, during the session. Not investment advice.